|Articles|May 1, 2004
- Pharmaceutical Executive-05-01-2004
May 2004 Table of Contents
May 2004 Table of Contents
Advertisement
Articles in this issue
over 21 years ago
The Risk Management Mandateover 21 years ago
Partners in Learningover 21 years ago
Early WarningsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
3
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
4
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
5
